US Broker Ratings

Cooper Companies, Inc. (COO) Stock Analysis: Investor Outlook Reveals 18.72% Potential Upside

The Cooper Companies, Inc. (NYSE: COO) stands as a prominent player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of..

Labcorp Holdings Inc. (LH) – Investor Outlook: Analyzing a Potential 17.78% Upside

Labcorp Holdings Inc. (NYSE: LH) is a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Burlington, North Carolina, Labcorp..

Viatris Inc. (VTRS) Stock Analysis: Exploring the 15.83% Potential Upside in a Challenging Market

Viatris Inc. (VTRS), a prominent player in the healthcare sector, has been the subject of investor scrutiny as it navigates a complex landscape of opportunities and..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 66% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) is a promising player in the biotechnology sector, specializing in innovative therapies that aim to improve the quality of life for..

Mettler-Toledo International (MTD) Stock Analysis: Navigating a Challenging Market with Precision

Mettler-Toledo International Inc. (NYSE: MTD), a leader in the diagnostics and research industry, is known for its precision instruments that serve a wide range of sectors..

Natera, Inc. (NTRA) Stock Analysis: Riding High on Innovation with a Market Cap of $27.3 Billion

Natera, Inc. (NTRA) has emerged as a formidable player in the diagnostics and research sector, demonstrating significant growth and innovation within the healthcare industry. With a..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a Strategic Path in Women’s Health with Solid Analyst Support

Investors with an eye on the healthcare sector might find Hologic, Inc. (NASDAQ: HOLX) a fascinating prospect. As a leader in medical instruments and supplies, Hologic..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 7.99% Potential Upside in the Healthcare Giant

Thermo Fisher Scientific Inc (NYSE: TMO), a dominant player in the healthcare sector, operates within the diagnostics and research industry, offering a vast array of life..

Bristol-Myers Squibb (BMY) Stock Analysis: Unveiling a 15% Upside Potential in the Healthcare Sector

Bristol-Myers Squibb Company (NYSE: BMY) stands as a stalwart in the healthcare sector, with a market capitalization of $93.79 billion. This American biopharmaceutical giant, headquartered in..

Sanofi (SNY) Stock Analysis: Exploring a 19.88% Upside with Robust Dividend Yield

Sanofi (SNY), the French healthcare titan, stands out in the competitive landscape of global pharmaceuticals. With a market capitalization of $124.45 billion, this drug manufacturer is..

UnitedHealth Group (UNH) Stock Analysis: Navigating a 12.84% Potential Upside with Robust Revenue Growth

UnitedHealth Group Incorporated (UNH), a formidable player in the healthcare sector, continues to capture investor attention with its expansive operations and diverse service offerings. Based in..

Edwards Lifesciences Corporation (EW) Stock Analysis: Unpacking a 13.4% Upside Potential

Edwards Lifesciences Corporation (NYSE: EW), a giant in the healthcare sector with a market capitalization of $48.41 billion, continues to attract investor interest with its innovative..

Revvity, Inc. (RVTY) Stock Analysis: 21.45% Potential Upside Beckons Investors

Revvity, Inc. (RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, is making waves in the investment community. With a market capitalization..

The Cigna Group (CI) Stock Analysis: A 40% Upside Potential Amid Strong Buy Ratings

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, is capturing investor attention with a compelling 40.42% potential upside. As the company stands at..

Gilead Sciences, Inc. (GILD) Stock Analysis: Target Price Reveals 8% Potential Upside for Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a powerhouse in the healthcare sector, stands as a prominent player within the drug manufacturing industry. With a substantial market capitalization..

Smith & Nephew SNATS, Inc. (SNN): An Investor Outlook on Healthcare’s Medical Device Innovator

Smith & Nephew SNATS, Inc. (NYSE: SNN) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the medical devices industry. With..

Merck & Co., Inc. (MRK) Investor Outlook: Analyzing a 18.35% Potential Upside with Strong Dividend Yields

Merck & Co., Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to capture investor attention with its robust pharmaceutical portfolio and promising growth prospects...

Align Technology, Inc. (ALGN) Investor Outlook: Analyzing 30.91% Potential Upside in a Transformative Healthcare Sector

Align Technology, Inc. (NASDAQ: ALGN) stands as a significant player in the healthcare sector, primarily known for its innovative contributions to the medical instruments and supplies..

CVS Health Corporation (CVS): Investor Outlook with a 15.83% Potential Upside and Robust Analyst Support

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, has consistently demonstrated its capacity to adapt and thrive in an ever-evolving industry. With..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 11.23% Potential Upside in the Medical Tech Giant

Intuitive Surgical, Inc. (NASDAQ: ISRG), a titan in the healthcare sector with a market cap of $189.4 billion, continues to revolutionize the field of minimally invasive..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds